Carcinoma de células escamosas labial: Características clínicas e histológicas de un caso
Palabras clave:
queilitis actínica, carcinoma de labio, diagnóstico oralResumen
La queilitis actínica es considerada la lesión potencialmente maligna más importante del carcinoma de células escamosas labial. Se encuentra comúnmente en individuos cuyas actividades ocupacionales están relacionadas con la exposición crónica al sol. El carcinoma de células escamosas (CCE) del labio representa aproximadamente 20% de todos los carcinomas orales con el labio inferior más comúnmente involucrado que el labio superior. Es más común en los hombres, alcanzando su punto máximo durante su sexta y séptima década, y es más frecuente en el labio inferior.
Descargas
Los datos de descargas todavía no están disponibles.
Citas
1. Düzgün S, Ünlü E, Pekdemir İ, Yilanci S, Ünlü RE. Management of Squamous Cell Carcinoma of The Lower Lip: Analysis of Five Years'Experience (78 Patients) and Review of The Literature KBB-Forum 2013; 12.
2. Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol 2011; 47 (11): 1048-54.
3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45 (4-5): 309-16.
4. Veness MJ, Ong C, Cakir B, Morgan G. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980- 1997. Australas Radiol 2001; 45 (2): 195-9.
5. Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, Soerjomataram I. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017; 67:51-64.
6. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013; 31:4550-9.
7. Viviano M, Addamo A, Lorenzini G. Oral Cancer. Int J Clin Dent 2013; 6 (3): 291-311.
8. Neville B. Epithelial Pathology. En: Neville B, Damm D, Allen C, Bouquot J, Dolan John, Oral and Maxillofacial Pathology. St. Louis, Estados Unidos: Editorial Saunders-Elsevier, 2009. p. 409-15.
9. de Visscher JG, Schaapveld M, Otter R, Visser O, van der Waal I (1998) Epidemiology of cancer of the lip in The Netherlands. Oral Oncol 34:421–426
10. Zitsch RP (1993) Carcinoma of the lip. Otolaryngol Clin North Am 26:265–277
11. Rena W, Lia Y, Liua C et al (2014) Surgical management of squamous cell carcinoma of the lower lip: an experience of 109 cases. Med Oral Patol Oral Cir Bucal 19(4):398–402
12. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin; 2009; 59: 27-41.
13. Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J LaryngolOtol; 2016; 130 (Suppl 2): S83–S89
14. Han AY, Kuan, Mallen-St Clair J, et al., Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis, JAMA Otolaryngol. Head Neck Surg. 142 (12) (2016) 1216–1223.
15. Maruccia M, Onesti MG, Parisi P, et al., Lip cancer: a 10-year retrospective epidemiological study, Anticancer Res. 32 (4) (2012) 1543–1546.
16. Calcaianu N, Popescu SA, Diveica D, Lascar I. Surgical attitude in premalignant lesions and malignant tumors of the lower lip. J Med Life, 2015, 8(1):109–111.
17. Lin YM, Sung WW, Hsieh MJ, et al. High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. PLoS One. 2015;10(11): e0142656.
18. Oliveira ML, Wagner VP, Sant'Ana FM, et al. A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay. Braz Oral Res. 2015;29: S1806-8324201500010027.
19. Alaeddini M, Etemad-Moghadam S. Correlation between invasion mode and the histologic risk assessment model in oral squamous cell carcinoma. Oral Maxillofac Surg. 2016;20(4): 353-358.
20. Radoi L, Luce D. A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community Dent Oral Epidemiol 2013; 41 (2): 97-109, e78-91.21. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884-94.
21. Neagu M, Caruntu C, Constantin C, Boda D, Zurac S, Spandidos DA, Tsatsakis AM. Chemically induced skin carcinogenesis: updates in experimental models (Review). Oncol Rep, 2016, 35(5):2516–2528.
22. Boda D, Neagu M, Constantin C, Voinescu RN, Caruntu C, Zurac S, Spandidos DA, Drakoulis N, Tsoukalas D, Tsatsakis AM. HPV strain distribution in patients with genital warts in a female population sample. Oncol Lett, 2016, 12(3):1779–1782.
23. Galyon SW, Frodel JL. Lip and perioral defects. Otolaryngol Clin North Am, 2001, 34(3):647–666.
24. Vieira RA, Minicucci EM, Marques ME, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol 2012; 87 (1): 105-14.
25. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol. 2012;66:173-84.
26. Savage NW, McKay C, Faulkner C. Actinic cheilitis in dental practice. Aust Dent J. 2010;55:78-84.
27. Pinera-Marques K, Lorenco SV, Silva LF, Sotto MN, Carneiro PC. Actinic lesions in fishermen’s lower lip: clinical, cytopathological and histopathologic analysis. Clinics (Sao Paulo). 2010;65:363-7.
28. Ron E. Cancer risks from medical radiation. Health Phys, 2003, 85(1):47–59.
29. Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis. 2009 Sep;15(6):388-99. https://doi.org/10.1111/j.1601-0825.2009.01563.x.
30. Ribeiro AO, Silva LC, Martins-Filho PR. Prevalence of and risk factors for actinic cheilitis in Brazilian fishermen and women. Int J Dermatol. 2014 Nov;53(11):1370-6. https://doi.org/10.1111/ijd.12526.
31. Biasoli, É. R., Valente, V. B., Mantovan, B., Collado, F. U., Neto, S. C., Sundefeld, M. L. M. M., & Bernabé, D. G. (2016). Lip cancer: a clinicopathological study and treatment outcomes in a 25-year experience. Journal of Oral and Maxillofacial Surgery, 74(7), 1360-1367. doi: 10.1016/j.joms.2016.01.041.
32. Czerninski R, Zini A, Sgan-Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970-2006. Br J Dermatol 2010; 162 (5): 1103-9.
33. Busick TL, Uchida T, Wagner RF. Preventing ultraviolet light lip injury: beachgoer awareness about lip cancer risk factors and lip protection behavior. Dermatol Surg 2005; 31 (2): 173-6.
34. Gutiérrez-Pascual M, Vicente-Martín FJ, Fernández-Álvarez JG, Martín-López R, Pinedo-Moraleda F, López-Estebaranz JL. Squamous cell carcinoma of the lip. A retrospective study of 146 patients. J Eur Acad Dermatol Venereol 2012; 26 (9): 1116-21.
35. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol. 2012;66:173-84.
36. Videnović G, Ilić D, Miljuš D, Krasić D, Vlahović Z, Živković S, Pavlović A. Lip, oral cavity and pharyngeal cancers in the population of the city of Belgrade in the period 1999-2010. Vojnosanit Pregl. 2016;73:53-8.
37. Gheno JN, Martins MAT, Munerato MC, Hugo FN, SANT’ANA FILHO M, Weissheimer C, et al. Oral mucosal lesions and their association with sociodemographic, behavioral, and health status factors. Braz Oral Res. 2015;29:1-6.
38. Hasson O. Squamous cell carcinoma of the lower lip. J Oral Maxillofac Surg 2008;66:1259–62.
39. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol 2010;3:39–48.
40. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003;56:85–91.
41. Prelec J, Laronde D. Treatment modalities of oral cancer. Canadian Journal of Dental Hygiene 2014; 48 (1): 13-9.
42. Supreet B , Mathivanan S, Merchant MI, Patil NS. Squamous Cell Carcinoma of Lower Lip Reconstructed with Bilateral Fan Flap. Ann Maxillofac Surg. 2019 Jan-Jun;9(1):211-213. doi: 10.4103/ams.ams_3_16.
43. Mello FW, Melo G, Modolo F, Rivero ER. Actinic cheilitis and lip squamous cell carcinoma: Literature review and new data from Brazil. J Clin Exp Dent. 2019 Jan 1;11(1):e62-e69. doi: 10.4317/jced.55133. e Collection 2019 Jan.
44. Sena LSB, Santos HBP, Amaral MGD, Gordon-Nuñez MA, Alves PM, Nonoka CFW. Immunoexpression of human leukocyte antigen-in actinic and lower lip squamous cell carcinoma. Braz Oral Res. 2019 Aug 29;33:e085. doi: 10.1590/1807-3107bor-2019.vol33.0085
2. Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol 2011; 47 (11): 1048-54.
3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45 (4-5): 309-16.
4. Veness MJ, Ong C, Cakir B, Morgan G. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980- 1997. Australas Radiol 2001; 45 (2): 195-9.
5. Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, Soerjomataram I. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017; 67:51-64.
6. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013; 31:4550-9.
7. Viviano M, Addamo A, Lorenzini G. Oral Cancer. Int J Clin Dent 2013; 6 (3): 291-311.
8. Neville B. Epithelial Pathology. En: Neville B, Damm D, Allen C, Bouquot J, Dolan John, Oral and Maxillofacial Pathology. St. Louis, Estados Unidos: Editorial Saunders-Elsevier, 2009. p. 409-15.
9. de Visscher JG, Schaapveld M, Otter R, Visser O, van der Waal I (1998) Epidemiology of cancer of the lip in The Netherlands. Oral Oncol 34:421–426
10. Zitsch RP (1993) Carcinoma of the lip. Otolaryngol Clin North Am 26:265–277
11. Rena W, Lia Y, Liua C et al (2014) Surgical management of squamous cell carcinoma of the lower lip: an experience of 109 cases. Med Oral Patol Oral Cir Bucal 19(4):398–402
12. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin; 2009; 59: 27-41.
13. Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J LaryngolOtol; 2016; 130 (Suppl 2): S83–S89
14. Han AY, Kuan, Mallen-St Clair J, et al., Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis, JAMA Otolaryngol. Head Neck Surg. 142 (12) (2016) 1216–1223.
15. Maruccia M, Onesti MG, Parisi P, et al., Lip cancer: a 10-year retrospective epidemiological study, Anticancer Res. 32 (4) (2012) 1543–1546.
16. Calcaianu N, Popescu SA, Diveica D, Lascar I. Surgical attitude in premalignant lesions and malignant tumors of the lower lip. J Med Life, 2015, 8(1):109–111.
17. Lin YM, Sung WW, Hsieh MJ, et al. High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma. PLoS One. 2015;10(11): e0142656.
18. Oliveira ML, Wagner VP, Sant'Ana FM, et al. A 10-year analysis of the oral squamous cell carcinoma profile in patients from public health centers in Uruguay. Braz Oral Res. 2015;29: S1806-8324201500010027.
19. Alaeddini M, Etemad-Moghadam S. Correlation between invasion mode and the histologic risk assessment model in oral squamous cell carcinoma. Oral Maxillofac Surg. 2016;20(4): 353-358.
20. Radoi L, Luce D. A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community Dent Oral Epidemiol 2013; 41 (2): 97-109, e78-91.21. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884-94.
21. Neagu M, Caruntu C, Constantin C, Boda D, Zurac S, Spandidos DA, Tsatsakis AM. Chemically induced skin carcinogenesis: updates in experimental models (Review). Oncol Rep, 2016, 35(5):2516–2528.
22. Boda D, Neagu M, Constantin C, Voinescu RN, Caruntu C, Zurac S, Spandidos DA, Drakoulis N, Tsoukalas D, Tsatsakis AM. HPV strain distribution in patients with genital warts in a female population sample. Oncol Lett, 2016, 12(3):1779–1782.
23. Galyon SW, Frodel JL. Lip and perioral defects. Otolaryngol Clin North Am, 2001, 34(3):647–666.
24. Vieira RA, Minicucci EM, Marques ME, Marques SA. Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects. An Bras Dermatol 2012; 87 (1): 105-14.
25. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol. 2012;66:173-84.
26. Savage NW, McKay C, Faulkner C. Actinic cheilitis in dental practice. Aust Dent J. 2010;55:78-84.
27. Pinera-Marques K, Lorenco SV, Silva LF, Sotto MN, Carneiro PC. Actinic lesions in fishermen’s lower lip: clinical, cytopathological and histopathologic analysis. Clinics (Sao Paulo). 2010;65:363-7.
28. Ron E. Cancer risks from medical radiation. Health Phys, 2003, 85(1):47–59.
29. Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis. 2009 Sep;15(6):388-99. https://doi.org/10.1111/j.1601-0825.2009.01563.x.
30. Ribeiro AO, Silva LC, Martins-Filho PR. Prevalence of and risk factors for actinic cheilitis in Brazilian fishermen and women. Int J Dermatol. 2014 Nov;53(11):1370-6. https://doi.org/10.1111/ijd.12526.
31. Biasoli, É. R., Valente, V. B., Mantovan, B., Collado, F. U., Neto, S. C., Sundefeld, M. L. M. M., & Bernabé, D. G. (2016). Lip cancer: a clinicopathological study and treatment outcomes in a 25-year experience. Journal of Oral and Maxillofacial Surgery, 74(7), 1360-1367. doi: 10.1016/j.joms.2016.01.041.
32. Czerninski R, Zini A, Sgan-Cohen HD. Lip cancer: incidence, trends, histology and survival: 1970-2006. Br J Dermatol 2010; 162 (5): 1103-9.
33. Busick TL, Uchida T, Wagner RF. Preventing ultraviolet light lip injury: beachgoer awareness about lip cancer risk factors and lip protection behavior. Dermatol Surg 2005; 31 (2): 173-6.
34. Gutiérrez-Pascual M, Vicente-Martín FJ, Fernández-Álvarez JG, Martín-López R, Pinedo-Moraleda F, López-Estebaranz JL. Squamous cell carcinoma of the lip. A retrospective study of 146 patients. J Eur Acad Dermatol Venereol 2012; 26 (9): 1116-21.
35. Jadotte YT, Schwartz RA. Solar cheilosis: an ominous precursor: part I. Diagnostic insights. J Am Acad Dermatol. 2012;66:173-84.
36. Videnović G, Ilić D, Miljuš D, Krasić D, Vlahović Z, Živković S, Pavlović A. Lip, oral cavity and pharyngeal cancers in the population of the city of Belgrade in the period 1999-2010. Vojnosanit Pregl. 2016;73:53-8.
37. Gheno JN, Martins MAT, Munerato MC, Hugo FN, SANT’ANA FILHO M, Weissheimer C, et al. Oral mucosal lesions and their association with sociodemographic, behavioral, and health status factors. Braz Oral Res. 2015;29:1-6.
38. Hasson O. Squamous cell carcinoma of the lower lip. J Oral Maxillofac Surg 2008;66:1259–62.
39. Jennings L, Schmults CD. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol 2010;3:39–48.
40. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003;56:85–91.
41. Prelec J, Laronde D. Treatment modalities of oral cancer. Canadian Journal of Dental Hygiene 2014; 48 (1): 13-9.
42. Supreet B , Mathivanan S, Merchant MI, Patil NS. Squamous Cell Carcinoma of Lower Lip Reconstructed with Bilateral Fan Flap. Ann Maxillofac Surg. 2019 Jan-Jun;9(1):211-213. doi: 10.4103/ams.ams_3_16.
43. Mello FW, Melo G, Modolo F, Rivero ER. Actinic cheilitis and lip squamous cell carcinoma: Literature review and new data from Brazil. J Clin Exp Dent. 2019 Jan 1;11(1):e62-e69. doi: 10.4317/jced.55133. e Collection 2019 Jan.
44. Sena LSB, Santos HBP, Amaral MGD, Gordon-Nuñez MA, Alves PM, Nonoka CFW. Immunoexpression of human leukocyte antigen-in actinic and lower lip squamous cell carcinoma. Braz Oral Res. 2019 Aug 29;33:e085. doi: 10.1590/1807-3107bor-2019.vol33.0085
Publicado
2020-03-30
Número
Sección
INVESTIGACIÓN
Licencia
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) después del su publicación en la revista, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
